Officer Files Intent to Sell Nearly $800K in Rapport Therapeutics Stock

summarizeSummary

An officer of Rapport Therapeutics, Krishnaswamy Yeleswaram, has filed a Form 144 indicating intent to sell approximately $800,000 worth of common stock, continuing a pattern of pre-planned sales.

check_boxKey Events

• Officer Files Intent to Sell Shares

  Krishnaswamy Yeleswaram, an officer of Rapport Therapeutics, filed a Form 144 to sell 20,225 shares of common stock.

• Significant Value of Proposed Sale

  The proposed sale has an approximate market value of $799,696.50.

• Part of Pre-Planned Program

  The sales are indicated to be part of a 10b5-1 trading plan adopted on December 10, 2025.

• Ongoing Insider Sales Pattern

  This filing is part of a series of Form 144 filings by the same officer and contributes to a broader pattern of insider distribution over the last 90 days.

auto_awesomeAnalysis

This Form 144 indicates an officer's intent to sell a notable amount of company stock, valued at approximately $800,000. While the sale is part of a pre-planned 10b5-1 program, which suggests it's not a discretionary signal of lack of confidence, it still represents a reduction in insider holdings. This filing continues a recent pattern of Form 144 filings from the same officer, as well as other insider selling activity observed over the past 90 days. Investors should monitor actual sales reported on Form 4 to track the execution of these planned dispositions.